Sumitomo Mitsui Trust Group
NBP

Sumitomo Mitsui Trust Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-84,883
Closed -$1.38M – 1238
2022
Q1 		$1.38M Buy
84,883
+5,578
+7% +$143K ﹤0.01% 1003
2021
Q4 		$3.76M Buy
79,305
+1,674
+2% +$100K ﹤0.01% 858
2021
Q3 		$5.63M Buy
77,631
+3,163
+4% +$229K ﹤0.01% 832
2021
Q2 		$6.25M Buy
+74,468
New +$4.91M ﹤0.01% 836

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group's NBP Position: Q2 2022 in Review

Sumitomo Mitsui Trust Group sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 84,883 shares — an estimated $1.38M sold.

Sumitomo Mitsui Trust Group first reported a position in NBP in Q2 2021 and held it in 4 quarters. The position peaked at $6.25M in Q2 2021. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

  • Sumitomo Mitsui Trust Group reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 84,883 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $1.38M.
  • Sumitomo Mitsui Trust Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 4 quarters.
  • Sumitomo Mitsui Trust Group's NovaBridge Biosciences American Depositary Shares position peaked at $6.25M in Q2 2021.
  • 97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2022, filed 26 Jul 2022.